MRI Online powered by Medality
Library

View this list on the Library Page

Pricing
MRI Online powered by Medality
MRI Online powered by Medality
MRI Online powered by Medality
Library

View this list on the Library Page

Pricing

31b - Answer: 63-year-old male presents with malignant neoplasm of prostate gland

Pomeranz, Stephen
Stephen J Pomeranz, MD
Chief Medical Officer, ProScan Imaging. Founder, MRI Online
Includes DICOM files

HISTORY: 

This 63-year-old male presents with malignant neoplasm of prostate gland. Followup study.

PRIMARY FINDING: 

PI-RADS 3 of 5.

FINDINGS:

Prostate gland measures 4.4cm in CC, 4.3cm in RL and 3.9cm in AP dimensions. Calculated prostate volume is 48cc. 

Transitional zone enlargement is noted. No suspicious T2 hypointense region with substantive diffusion restriction or early arterial enhancement to suggest malignant neoplastic process in the peripheral zone. Transitional zone hyperplasia is mostly stromal in nature which demonstrates moderate diffusion restriction. No discrete T2 hypointense area with substantive diffusion restriction to suggest malignant neoplastic process in the transitional zone. Anatomical prostate capsule, bilateral neurovascular bundles and atrophic seminal vesicles are clear. 

No enlarged lymph nodes in the pelvis or inguinal regions. 

Urinary bladder is distended and unremarkable. Mild indentation of the enlarged transitional zone to urinary bladder floor is noted. 

Rectum wall is clear. Visualized aspects of the bowel wall are normal in caliber. 

No abnormal osseous enhancement. 

Small fat-containing inguinal hernias right greater than left. 

Mild capsulitis of the right hip joint. 

CONCLUSION

1. PI-RADS 3 of 5, transitional zone hyperplasia with areas of moderate diffusion restriction in mid and apical segments. 

2. Mild capsulitis of the right hip joint. 

3. Small fat-containing inguinal hernias, right greater than left.

LESSON 3, TOPIC 18

Case Challenge: Prostate MRI Cases

Case Challenge

Browse other topics in...

Content reviewed: October 25, 2021

View CME activity information